Takeda Pharmaceutical Co. and Daiichi Sankyo Co. are each considering producing vaccines for new and seasonal influenza, a move that would likely increase sharply supplies of domestically produced vaccines, sources close to the matter said Monday.

To access full stories on Kyodo News English website, it is necessary to subscribe. Please contact Kyodo's International Department in Tokyo via e-mail at kokusai@kyodonews.jp or call 03-6252-8301. If you are outside Japan, please contact Kyodo News International in New York at kni@kyodonews.com or call +1-212-508-5440. Currently we offer subscriptions to only corporate clients such as newspapers, magazines, trade publications, research institutes, government and international organizations.